These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3939569)
1. [Various aspects of the use of liposomes in the diagnosis, prophylaxis and treatment of infectious diseases]. Zakrevskiĭ VI Mol Gen Mikrobiol Virusol; 1985 Jan; (1):3-9. PubMed ID: 3939569 [TBL] [Abstract][Full Text] [Related]
2. [Biological properties of liposomes and their practical application]. Halyts'ka SM; Nikol's'kyĭ IS Fiziol Zh (1994); 2008; 54(5):99-108. PubMed ID: 19058519 [TBL] [Abstract][Full Text] [Related]
3. [Trends in the development of research in the field of liposomes (review of patent literature)]. Nesytova NIu; Paleva NS; Il'ina EV; Shenk P; Bendas F; Nun P Vestn Akad Med Nauk SSSR; 1990; (6):8-19. PubMed ID: 2220043 [TBL] [Abstract][Full Text] [Related]
4. [Possibility of the unification of directed drug transport as illustrated by liposome transport to target antigens]. Trubetskoĭ VS; Berdichevskiĭ VR; Efremov EE; Torchilin VP; Smirnov VN Biull Eksp Biol Med; 1986 Sep; 102(9):305-7. PubMed ID: 3756331 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Liposomes as delivery systems in the prevention and treatment of infectious diseases. Bergers JJ; ten Hagen TL; van Etten EW; Bakker-Woudenberg IA Pharm World Sci; 1995 Jan; 17(1):1-11. PubMed ID: 7719272 [TBL] [Abstract][Full Text] [Related]
7. Long-circulating sterically stabilized liposomes in the treatment of infections. Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385 [TBL] [Abstract][Full Text] [Related]
8. Lipid A and liposomes containing lipid A as antigens and adjuvants. Alving CR; Rao M Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433 [TBL] [Abstract][Full Text] [Related]
10. The liposomal formulation of doxorubicin. Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Lopes de Menezes DE; Pilarski LM; Allen TM Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662 [TBL] [Abstract][Full Text] [Related]
12. Treatment of experimental osteomyelitis by liposomal antibiotics. Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Alipour M; Halwani M; Omri A; Suntres ZE Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881 [TBL] [Abstract][Full Text] [Related]
14. Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein. Rao M; Rothwell SW; Wassef NM; Koolwal AB; Alving CR Exp Cell Res; 1999 Jan; 246(1):203-11. PubMed ID: 9882529 [TBL] [Abstract][Full Text] [Related]
15. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. Brgles M; Habjanec L; Halassy B; Tomasić J Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317 [TBL] [Abstract][Full Text] [Related]
16. [Current status of the problem of the treatment and prevention of hereditary diseases]. Davidenkova EF Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):9-17. PubMed ID: 7043988 [TBL] [Abstract][Full Text] [Related]
17. [Antibiotic treatment for prevention of infectious complications in joint replacement]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Apr; 73(2):108-14. PubMed ID: 16735008 [TBL] [Abstract][Full Text] [Related]
19. Adjuvanted subunit vaccines for the control of Salmonella enteritidis infection in turkeys. Charles SD; Hussain I; Choi CU; Nagaraja KV; Sivanandan V Am J Vet Res; 1994 May; 55(5):636-42. PubMed ID: 8067610 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine. Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]